Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Postbiotics Show Promise in Slowing Liver Fibrosis
July 2025
While the primary outcome, a ≥10% reduction in α-SMA, was reached in 29% of ReFerm® recipients versus 14% in the control group, the difference was not statistically significant.
Read more
11 May 2024
Improved Survival Outcomes Associated with Hepatocellular Carcinoma Screening
A recent study demonstrates hepatocellular carcinoma screening in patients with liver disease and cirrhosis to be associated with improved early-stage tumour detection and survival, persisting after lead-time and length-time bias adjustment.
11 May 2024
Decreased Bone Mineral Density Associated with Heightened Cirrhosis Risk
A new research from the University of Hong Kong has identified bone mineral density as a potentially novel risk factor and early predictor for cirrhosis development. Read more.
13 Mar 2024
Optimising Outcomes in Patients with Hepatitis-Associated Aplastic Anaemia
Exploring strategies to optimise outcomes for those with HAAA, and assessing both safety and efficacy of HSCT was the goal of an emerging piece of research.
12 Mar 2024
Dietary Acid Load Significantly Associated with Cirrhosis-Related Mortality
According to research, dietary acid load is significantly associated with cirrhosis-related mortality, and there is further need of investigating underlying mechanisms, as well as establishing optimal DAL levels in patients with cirrhosis.
19 Jan 2024
Low Screening and Treatment for Osteoporosis in Patients with Cirrhosis
Screening for osteoporosis is considerably lower in patients with cirrhosis compared with the general population, and less than 25% of those with low bone density are treated, according to a recent study. Read more.
8 Nov 2023
Does Testosterone Replacement Improve Steatotic Liver Disease?
Male hypogonadism is associated with visceral obesity and metabolic syndrome. The present study aims to compare the effects of testosterone treatment with a placebo in treating non-alcoholic fatty liver disease in older hypogonadal males.
7 Nov 2023
Novel Scoring Tool Predicts Alcoholic Relapse Following Liver Transplant
New data suggests that the risk of alcoholic relapse in patients with alcohol-related liver disease who underwent liver transplant may be more accurately determined with the help of a new scoring system.
13 Oct 2023
Waitlist Outcomes Improved by Living Donor Liver Transplantation
Waitlist outcomes are improved by living donor liver transplantation for high-risk patients with cirrhosis, according to a recent study. This study aimed to assess the impact of access to LDLT in waitlisted patients at highest risk of dropout.
Loading posts...
« Previous
1
…
17
18
19
20
21
…
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View